Massachusetts Financial Services CO Acadia Pharmaceuticals Inc Transaction History

Massachusetts Financial Services CO

$303 Billion
Q3 2025

A detailed history of Massachusetts Financial Services CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 1,110,726 shares of ACAD stock, worth $24.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,110,726

Previous 58,688 1792.59%

Holding current value

$24.3 Million

Previous $1.27 Million 1773.68%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	BUY	$20.88 - $26.57 $22 Million - $28 Million	1,052,038 Added 1792.59%	1,110,726 $23.7 Million
Q2 2025 Aug 08, 2025	BUY	$14.1 - $22.95 $10,222 - $16,638	725 Added 1.25%	58,688 $1.27 Million
Q1 2025 May 02, 2025	SELL	$16.61 - $20.29 $21,925 - $26,782	-1,320 Reduced 2.23%	57,963 $962,000
Q4 2024 Feb 12, 2025	SELL	$14.29 - $18.76 $25,264 - $33,167	-1,768 Reduced 2.9%	59,283 $1.09 Million
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $22,392 - $28,308	-1,479 Reduced 2.37%	61,051 $939,000
Q2 2024 Aug 09, 2024	BUY	$14.62 - $18.42 $30,702 - $38,682	2,100 Added 3.48%	62,530 $1.02 Million
Q1 2024 May 14, 2024	SELL	$17.79 - $30.86 $2,383 - $4,135	-134 Reduced 0.22%	60,430 $1.12 Million
Q4 2023 Feb 08, 2024	BUY	$20.78 - $31.77 $1.26 Million - $1.92 Million	60,564 New	60,564 $1.9 Million
Q2 2018 Jul 30, 2018	SELL	$15.07 - $22.34 $3.74 Million - $5.55 Million	-248,233 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$22.47 - $32.33 $1.49 Million - $2.14 Million	66,283 Added 36.43%	248,233 $5.58 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $64,791 - $94,483	2,414 Added 1.34%	181,950 $5.48 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $32,321 - $42,053	1,096 Added 0.61%	179,536 $6.76 Million
Q2 2017 Aug 14, 2017	BUY	N/A	178,440	178,440 $4.98 Million

Others Institutions Holding ACAD

# of Institutions

354

Shares Held

164M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.54B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Acadia Pharmaceuticals Inc Transaction History